Prioritising HTA funding: The benefits and challenges of using value of information in anger CENTRE FOR HEALTH ECONOMICS K Claxton, L Ginnelly, MJ Sculpher,

Slides:



Advertisements
Similar presentations
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized control trial (BMJ. 2010;341:c5462)
Advertisements

Technology Appraisal of Medical Devices at NICE – Methods and Practice Mark Sculpher Professor of Health Economics Centre for Health Economics University.
USE OF EVIDENCE IN DECISION MODELS: An appraisal of health technology assessments in the UK Nicola Cooper Centre for Biostatistics & Genetic Epidemiology,
USE OF EVIDENCE IN DECISION MODELS: An appraisal of health technology assessments in the UK Nicola Cooper Centre for Biostatistics & Genetic Epidemiology,
Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty Karl Claxton Centre for Health Economics*, Department of Economics and Related Studies,
When is there Sufficient Evidence? Karl Claxton, Department of Economics and Related Studies and Centre for Health Economics, University of York.
Making Decisions in Health Care: Cost-effectiveness and the Value of Evidence Karl Claxton Centre for Health Economics, Department of Economics and Related.
In Search of Efficiency, Consistency, Fairness, and Impact in HTA: Modelling screening and treatment pathways for diabetic retinopathy Graham Scotland.
Value of information An innovative approach to prioritizing comparative effectiveness research AHRQ Annual Meeting September 29, 2010.
1 Value of Information Yot Teerawattananon, MD International Health Policy Program, Ministry of Public Health PhD candidate in Health Economics, University.
Optimal Drug Development Programs and Efficient Licensing and Reimbursement Regimens Neil Hawkins Karl Claxton CENTRE FOR HEALTH ECONOMICS.
Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions A Case Study in Type.
Populating decision analytic models Laura Bojke, Zoë Philips With M Sculpher, K Claxton, S Golder, R Riemsma, N Woolacoot, J Glanville.
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
Therapeutic exercise foundation and techniques Therapeutic exercise foundation and concepts Part II.
The Importance of Decision Analytic Modelling in Evaluating Health Care Interventions Mark Sculpher Professor of Health Economics Centre for Health Economics.
A Role for Decision Analysis in PHIAC? Mark Sculpher Centre for Health Economics University of York.
Cost-Effectiveness Analyses in the UK - Lessons from the National Institute for Clinical Excellence Mark Sculpher Professor of Health Economics Centre.
Structural uncertainty from an economists’ perspective
The Cost-Effectiveness and Value of Information Associated with Biologic Drugs for the Treatment of Psoriatic Arthritis Y Bravo Vergel, N Hawkins, C Asseburg,
Dangerous Omissions – the Cost of Ignoring Decision Uncertainty Mark Sculpher Susan Griffin Karl Claxton Steve Palmer Centre for Health Economics, University.
The Use of Economic Evaluation For Decision Making: Methodological Opportunities and Challenges Mark Sculpher Karl Claxton Centre for Health Economics.
The Role of Trial-based Economic Evaluation in Health Care Decision Making Discussion Mark Sculpher Centre for Health Economics University of York iHEA,
NICE in a changing world National Leading Improvement for Health and Well-being programme 12 May 2011 Gillian Mathews Implementation consultant.
Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.
Patient Empowerment in Chronic Obstructive Pulmonary Disease (COPD) Noreen Baxter Respiratory Nurse Specialist May 2005.
05/12/04 Lung Health StudySlide 1 of 6 Lung Health Study Heavy Smokers Experienced a Greater Benefit in the Reduction of the Decline Rate of their Pulmonary.
Treatment of urinary tract infections
Prof.Hanan Habib. To eradicate the offending organisms from the urinary bladder and tissues. The main treatment of UTI is by antibiotics.
HIGH DOSES OF VITAMIN D TO REDUCE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL An Lehouck, PhD; Chantal Mathieu, MD, PhD;
Quality Cancer Data The Vital Role of Cancer Registrars in the Fight against Cancer Saves Lives.
Studying treatment of suicidal ideation & attempts: Designs, Statistical Analysis, and Methodological Considerations Jill M. Harkavy-Friedman, Ph.D.
The Big Puzzle Evolving the Continuum of Care. Agenda Goal Pre Acute Care Intra Hospital Care Post Hospital Care Grading the Value of Post Acute Providers.
Naomi McVey Commissioning Adviser, NICE March 2013 Quality standards- NICE and the new NHS.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
Electronic Health Records and Clinical Decision Support Systems Impact on National Ambulatory Care Quality Max J. Romano, BA; Randall S. Stafford, MD,
The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
Treatment of urinary tract infections Prof. Hanan Habib.
TA298 Ranibizumab for treating choroidal neovascularisation associated with pathological myopia Dr.Muhammad Hamza North Devon District NHS Hospital NICE.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Renal Services Dr Donal O’Donoghue National Clinical Director for Kidney Care UKRR Annual Audit Meeting QEH Birmingham 30 September 2010 Working for Better.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
UNDERSTANDING AND DEFINING QUALITY Quality Academy – Cohort 6 April 8, 2013.
Louisa Hemington ST5 General Paediatrics Oct 2015 Does prompt treatment of UTI in preschool children prevent renal scarring?
Treatment of urinary tract infections
Older People’s Services The Single Assessment Process.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
PANEL SESSION: MODELLING HETEROGENEITY IN COST-EFFECTIVENESS ANALYSIS Modelling variation for decision making Mark Sculpher, PhD Centre for Health Economics,
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
Childhood urinary tract infections as a cause of chronic kidney disease.
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Lancet Respir Med 2013; 1: 199–209 R4.신재령 / Prof. 박명재
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Focus on health and care of mothers and infants ChiMat conference, 2009 Professor Mary Renfrew Mother and Infant Research Unit.
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
School of Allied Health Professions & School of Medicine, Health Policy & Practice LAMP A pragmatic unblinded randomised controlled trial and economic.
The Advanced Practitioner in Primary Care Dr Deborah Atkinson MSc BSc(hons) RN.
The Patient Centered Medical Home. Learning Objectives Identify the attributes of a patient centered medical home Describe some processes that facilitate.
admissions in residents in care homes.
A quick reference to literature searches
Management of Urinary Tract Infections Renal Block
Management of Urinary Tract Infections Renal Block
How should we test for pre-term labour
Angelica Abad, Rachel Trengrove and Naomi Fleming Abstract 181
CSP Pulmonary Rehabilitation Impact Model on Exacerbations (PRIME) tool How to calculate impact of PR provision to all the eligible COPD patients across.
Presentation transcript:

Prioritising HTA funding: The benefits and challenges of using value of information in anger CENTRE FOR HEALTH ECONOMICS K Claxton, L Ginnelly, MJ Sculpher, Z Philips. Centre for Health Economics, University of York, UK

Overview Overview of methods Screening for age-related macular degeneration –Considered by NCCHTA diagnostic and screening panel Manual chest physiotherapy techniques for asthma and chronic obstructive pulmonary disease –Considered by NCCHTA therapeutic procedures panel long-term antibiotic treatment for preventing recurrent urinary tract infections (UTI) in children –Considered by Prioritisation Strategy Group (PSG)

An overview of methods Background Other methods –Research as a means changing clinical practice Statistical decision theory –Reduction in the costs of decision uncertainty –Value consistent with objective and constraints of service provision Methods Constructions of decision analytic model Probabilistic analysis to characterise decision uncertainty Value of information analysis

Identifying research priorities EVPI –Maximum return to research (decision problem) –Comparing the EVPI to the costs of research –Comparing EVPI across technologies Partial EVPI –Maximum return to research (endpoint) –Comparing partial EVPIs –Considering the costs of research

Options Weekly self screening with Amsler grid No screen but self referral on decline in visual acuity No PDT treatment and no screening Indications 1 st eye neovascular AMD 20/40 and 20/80 visual acuity Male and female (age 55-64) Eligibility of PDT consistent with NICE guidance Time horizon of 10 years NHS Perspective Screening for age-related macular degeneration (AMD)

Model structure for AMD screening

Patient groups Children treated in the community Adults treated in the community Children treated in hospital Options Massage therapy Chiropractic spinal manipulation (CSM) Physical therapy No manual therapy Time horizon of 30-days NHS perspective Manual chest physiotherapy techniques for asthma

Patient groups Adults with stable COPD Options Autogenic drainage Active breathing, Heat lamp Chest percussion with drainage No manual therapy Time horizon of 30-days NHS perspective Manual Chest Physiotherapy Techniques for adults with Chronic Obstructive Pulmonary Disease (COPD)

Structure of the asthma and COPD model

Patient groups Infants of 1 year and children age 3 Girls and boys Recurrent UTI (no abnormalities) Mild VUR (grade I and II) Options Long-term low dose antibiotics (Cochrane review) (Trimethoprim, Nitrofurantoin, Cotrimoxazole) Intermittent treatment of UTIs Time horizon 3 years of long-term antibiotics and follow-up to end stage renal disease NHS perspective long-term antibiotic treatment for preventing recurrent urinary tract infections (UTI) in children

Model Structure for UTI

The evidence Effectiveness Existing reviews (variable quality) Meta analysis, Multiple parameter synthesis Probabilistic trial based model Natural history Epidemiological studies Pooled trial baselines Registry studies Clinical judgement Quality of life Published studies Survey Costs Published studies Published unit costs and dosage (BNF, PSSRU, CIPFA)

Results: cost-effectiveness acceptability curve

Results: population EVPI (girls age 3 with no VUR)

Partial EVPI (girls age 3 with no VUR)

Results: EVPI TopicPatient GroupPopulation EVPIPartial EVPI AMD Screening20/40 20/80 £6,950,000 £18,220,000 Quality of life with and without PDT Asthma Physiotherapy COPD Physiotherapy Children in Community Adults in Community Children in Hospital Adults in Community £14,500,000 0 £1,200,000 0 Effect of massage - Effect on LOS and FEV - UTI prophylaxisGirls 3, no VUR Girls 3, VUR Girls 1, no VUR Girls 1, VUR Boys 3, no VUR Boys 3, VUR Boys 1, no VUR Boys 1, VUR £2,240,000 £613,000 £690,000 £544,000 £41,000 £23,000 £267,000 £176,000 Effect of prophylaxis on UTI Effect < 6 months Effect of: Trimethoprim Cotrimoxazole Nitrofurantoin

Conclusions Asthma Children treated in the community –Massage therapy may be cost-effective –Further research is potentially cost-effective –Effect of massage therapy on FEV 1 (no value in effect of CSM ) Manual physiotherapy for adults treated in the community –Manual therapy not cost effective –Further research not cost-effective Children treated in hospital –Physical therapy may be cost-effective –Further research is potentially cost-effective –Effect of physical therapy on hospital length of stay and FEV 1 COPD –Manual chest physiotherapy for stable COPD is not cost-effective. –Further research not cost-effective –Inpatient manual chest physiotherapy?

Conclusions AMD –Screening may be cost-effective –Further research appears to be potentially cost-effective –Evidence about the quality of life with and without PDT UTI Prophylaxis –Long-term antibiotics are cost-effective for all patient groups Which of the antibiotics should be used is uncertain –Primary research maybe required for selected patient groups girls age 3 with no VUR –Trials should include head to head comparisons Cotrimoxazole and trimethoprim or all three antibiotics –Longer follow-up would be worthwhile trials with 6 month follow-up are unlikely to be worthwhile

Feasibility and policy impact Feasibility –Completed despite not meeting selection criteria –Analysis conducted and presented within NCCHTA time lines Policy impact –Mixed responses from panel members –Potential (selective) role at PSG –Impact on commissioning decisions

Methods and implementation Methods –More complex and resource intensive than anticipated –Comprehensive searching for model parameters –Methods of evidence synthesis –Quality of evidence (bias and exchangeability) –Sensitivity analysis (evidence, model structure) Implementation –Communicating complex material –Requires an iterative process –Identifying topics where VoI should be conducted